BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16088891)

  • 1. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
    von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
    J Biomed Mater Res A; 2005 Nov; 75(2):288-94. PubMed ID: 16088891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of simvastatin on polyethylene particle-induced osteolysis.
    von Knoch F; Heckelei A; Wedemeyer C; Saxler G; Hilken G; Henschke F; Löer F; von Knoch M
    Biomaterials; 2005 Jun; 26(17):3549-55. PubMed ID: 15621245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis.
    von Knoch F; Wedemeyer C; Heckelei A; Saxler G; Hilken G; Brankamp J; Sterner T; Landgraeber S; Henschke F; Löer F; von Knoch M
    Biomaterials; 2005 Oct; 26(29):5783-9. PubMed ID: 15869791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles.
    Masui T; Sakano S; Hasegawa Y; Warashina H; Ishiguro N
    Biomaterials; 2005 May; 26(14):1695-702. PubMed ID: 15576143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
    Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
    Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.
    Goater JJ; O'Keefe RJ; Rosier RN; Puzas JE; Schwarz EM
    J Orthop Res; 2002 Mar; 20(2):169-73. PubMed ID: 11918293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.
    Childs LM; Paschalis EP; Xing L; Dougall WC; Anderson D; Boskey AL; Puzas JE; Rosier RN; O'Keefe RJ; Boyce BF; Schwarz EM
    J Bone Miner Res; 2002 Feb; 17(2):192-9. PubMed ID: 11811549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
    Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
    J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(-/-) mice.
    Ren W; Wu B; Peng X; Hua J; Hao HN; Wooley PH
    J Orthop Res; 2006 Aug; 24(8):1575-86. PubMed ID: 16779834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles.
    Granchi D; Amato I; Battistelli L; Ciapetti G; Pagani S; Avnet S; Baldini N; Giunti A
    Biomaterials; 2005 May; 26(15):2371-9. PubMed ID: 15585240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
    Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F
    Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation.
    Granchi D; Ciapetti G; Amato I; Pagani S; Cenni E; Savarino L; Avnet S; Peris JL; Pellacani A; Baldini N; Giunti A
    Biomaterials; 2004 Aug; 25(18):4037-45. PubMed ID: 15046894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
    Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
    J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A; Kudo O; Athanasou NA
    J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo.
    Ren WP; Markel DC; Zhang R; Peng X; Wu B; Monica H; Wooley PH
    Biomaterials; 2006 Oct; 27(30):5161-9. PubMed ID: 16814378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The decrease of particle-induced osteolysis after a single dose of bisphosphonate.
    von Knoch M; Wedemeyer C; Pingsmann A; von Knoch F; Hilken G; Sprecher C; Henschke F; Barden B; Löer F
    Biomaterials; 2005 May; 26(14):1803-8. PubMed ID: 15576154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
    Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo.
    von Knoch M; Jewison DE; Sibonga JD; Sprecher C; Morrey BF; Loer F; Berry DJ; Scully SP
    J Orthop Res; 2004 Mar; 22(2):237-43. PubMed ID: 15013080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
    Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
    Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
    Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
    Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.